2m 2m 2m 2m 2m 2m 2m
MOONLAKE IMM-A (MLTX)
NASDAQ
$18.34+$0.47 (+2.63%)
Price as of Jun 03, 2026 6:14 PM EDT- $1.2BMarket Cap
- -63.19%1-Year Change
- BiotechnologyIndustry
MOONLAKE IMM-A (MLTX)
$18.34+$0.47 (+2.63%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -202.9M +79.89% | -112.8M +254.61% | -31.8M -24.37% | -42.0M N/A | |
Depreciation and Amortization Expense | 2.6M +88.92% | 1.4M +10,423.86% | 13,158 +6.47% | 12,358 N/A | |
Total Operating Expenses | 244.8M +71.10% | 143.1M +164.38% | 54.1M -16.81% | 65.1M +1,323.56% | |
Operating Profit | -244.8M +71.10% | -143.1M +164.38% | -54.1M -16.81% | -65.1M +1,323.56% | |
Interest Income | 22.4M +1.10% | 22.1M +118.27% | 10.1M N/A | N/A N/A | |
Interest Expense | -7.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 15.2M -31.44% | 22.1M +118.27% | 10.1M N/A | 0 -100.00% | |
Total Nonoperating Income and Expense | 22.4M +1.10% | 22.1M +118.27% | 10.1M +1,613.34% | 591,732 +2,036.91% | |
Income before Taxes | -229.7M +89.90% | -121.0M +175.01% | -44.0M -31.77% | -64.5M +1,310.61% | |
Income Taxes | 611,000 +116.51% | 282,199 +198.98% | 94,388 +159.55% | 36,366 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -227.3M +91.13% | -118.9M +230.31% | -36.0M -27.95% | -50.0M +1,000.09% | |
Net Income from Continuing Operations Applicable to Common | -227.3M +91.13% | -118.9M +230.31% | -36.0M -27.95% | -50.0M +1,000.09% | |
Basic EPS and Net Income | -3.53 +86.77% | -1.89 +158.90% | -0.73 -57.06% | -1.70 +448.39% | |
Diluted EPS and Net Income | -3.53 +86.77% | -1.89 +158.90% | -0.73 -57.06% | -1.70 +448.39% | |
Basic Weighted Average Shares | 64.5M +2.53% | 62.9M +27.99% | 49.1M +67.30% | 29.4M +146.11% | |
Diluted Weighted Average Shares | 64.5M +2.53% | 62.9M +27.99% | 49.1M +67.30% | 29.4M +146.11% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 334.5M +85.40% | 180.4M -60.01% | 451.2M +1,042.04% | 39.5M +5,824.75% | |
Short-Term Investments | 59.5M -77.78% | 267.6M +347.20% | 59.8M +83.50% | 32.6M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 394.0M -12.07% | 448.0M -12.32% | 511.0M +608.60% | 72.1M +10,715.21% | |
Total Current Assets | 421.7M -11.09% | 474.3M -7.76% | 514.2M +572.01% | 76.5M +9,539.76% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 577,000 -20.11% | 722,226 +125.09% | 320,865 +549.67% | 49,389 N/A | |
Total Long-Term Assets | 2.7M -24.84% | 3.6M -70.54% | 12.4M +3,627.10% | 331,969 -99.71% | |
Total Assets | 424.4M -11.19% | 477.9M -9.23% | 526.5M +585.21% | 76.8M -33.66% | |
Income Taxes Payable | 1.1M +70.37% | 642,114 +74.50% | 367,976 +235.05% | 109,826 N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Current Liabilities | 45.5M +102.45% | 22.5M +125.41% | 10.0M +30.01% | 7.7M +98.06% | |
Total Long-Term Debt | 74.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 74.5M +3,483.44% | 2.1M -32.60% | 3.1M +649.94% | 411,157 -89.78% | |
Total Liabilities | 120.0M +388.76% | 24.5M +88.08% | 13.0M +61.57% | 8.1M +2.30% | |
Retained Earnings | -462.9M +96.49% | -235.6M +101.95% | -116.7M +44.65% | -80.7M +1,042.47% | |
Total Stockholders Equity | 304.5M -31.86% | 446.8M -9.86% | 495.7M +913.69% | 48.9M +792.71% | |
Total Shares Outstanding | 71.4M +35.43% | 52.7M 0.00% | 52.7M 0.00% | 52.7M +1,494.59% | |
Cash Flow | |||||
Cash from Operating Activities | -196.0M +68.12% | -116.6M +172.54% | -42.8M -23.47% | -55.9M +9,046.87% | |
Capital Expenditures | 35,000 -93.26% | 519,520 +82.52% | 284,634 +1,677.96% | 16,009 N/A | |
Cash from Investing Activities | 203.0M +198.73% | -205.6M +716.36% | -25.2M -22.13% | -32.3M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 146.0M +184.53% | 51.3M -89.30% | 479.7M +300.78% | 119.7M +206,242.87% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -50.38% +112.75% | -23.68% +98.42% | -11.94% -76.99% | -51.87% +1,227.26% | |
Return on Equity | -60.51% +139.77% | -25.24% +90.85% | -13.22% -94.46% | -238.88% -351.76% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 9.27 -56.08% | 21.11 -59.08% | 51.59 +416.90% | 9.98 +4,766.55% | |
Cash Ratio | 7.36 -8.42% | 8.03 -82.26% | 45.27 +778.44% | 5.15 +2,891.12% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow